| 11/3/2025 | 13:34 | GLOBE | Coeptis Therapeutics Secures Worldwide Development and.. |
| 07/3/2025 | 14:37 | GLOBE | COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to.. |
| 20/2/2025 | 15:00 | GLOBE | COEPTIS’ NexGenAI Partners with Arketyp Valu to.. |
| 20/2/2025 | 13:27 | GLOBE | COEPTIS NexGenAI Affiliates Network & MarketLeverage.. |
| 19/2/2025 | 22:00 | GLOBE | COEPTIS NexGenAI Affiliates Network & MarketLeverage.. |
| 13/2/2025 | 15:10 | IHNW | COEPTIS Announces the Launch of COEP Venture Group to Invest.. |
| 13/2/2025 | 14:39 | GLOBE | COEPTIS Announces the Launch of COEP Venture Group to Invest.. |
| 06/2/2025 | 14:08 | PRNUS | COEPTIS Completes $10 Million Series A Preferred Financing.. |
| 30/1/2025 | 14:27 | PRNUS | Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a.. |
| 23/1/2025 | 14:09 | PRNUS | Coeptis Therapeutics Leverages Artificial Intelligence and.. |
| 22/1/2025 | 14:00 | PRNUS | Coeptis Therapeutics Regains Compliance with Nasdaq Listing.. |
| 07/1/2025 | 14:00 | PRNUS | Coeptis Therapeutics Announces First Customer Adoptions of.. |
| 31/12/2024 | 20:20 | APS | Trading Halt Occurred During This Micro Cap's EOY Surge |
| 27/12/2024 | 14:15 | PRNUS | Coeptis Therapeutics Announces Reverse Stock Split |
| 26/12/2024 | 14:15 | PRNUS | Coeptis Therapeutics Makes Bold Strides in Innovation with.. |
| 12/12/2024 | 14:00 | PRNUS | Coeptis Therapeutics Unveils New Technology Division:.. |
| 03/12/2024 | 14:15 | PRNUS | Coeptis Therapeutics Executes Binding Letter of Intent to.. |
| 07/11/2024 | 14:07 | PRNUS | Coeptis Therapeutics Announces Phase 1 Data on DVX201 for.. |
| 24/10/2024 | 14:07 | PRNUS | Coeptis Therapeutics Expands License Agreement with Deverra.. |
| 15/10/2024 | 14:07 | PRNUS | Coeptis Therapeutics' Chief Scientific and Medical Officer.. |
| 19/9/2024 | 13:07 | PRNUS | Coeptis Therapeutics Regains Compliance with Nasdaq Minimum.. |
| 05/9/2024 | 14:07 | PRNUS | Coeptis Therapeutics Chief Executive Officer, Dave Mehalick,.. |
| 16/8/2024 | 22:02 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 16/8/2024 | 22:01 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 14/8/2024 | 23:26 | EDGAR2 | Form NT 10-Q - Notification of inability to timely file Form.. |
| 14/8/2024 | 23:25 | EDGAR2 | Form 8-K - Current report |
| 31/7/2024 | 23:00 | EDGAR2 | Form 8-K - Current report |
| 20/6/2024 | 14:47 | PRNUS | Coeptis Therapeutics Closes on $4.3 Million of Series A.. |
| 30/5/2024 | 14:47 | PRNUS | Coeptis Therapeutics' Dr. Colleen Delaney to Present at.. |
| 08/5/2024 | 14:47 | PRNUS | Coeptis Therapeutics to Present its Universal Allogeneic.. |
| 02/5/2024 | 14:47 | PRNUS | Coeptis Therapeutics Announces Poster Data Presentation at.. |
| 02/4/2024 | 14:47 | PRNUS | Coeptis Therapeutics Congratulates Alexander Deiters,.. |
Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
![Logo di PlayCoin [Qtum] (PLYUSD).](/common/images/company/COIN_PLYUSD.png){kind=small}
